tiprankstipranks
Kymera Therapeutics (KYMR)
NASDAQ:KYMR
US Market
Want to see KYMR full AI Analyst Report?

Compare Kymera Therapeutics (KYMR) vs. Competitors

433 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Kymera Therapeutics
$87.71
$7.08B
-29.33
179.75%
16 Buy
0 Hold
0 Sell
Strong Buy
Protagonist Therapeutics
$105.98
$6.39B
453.36
126.23%
10 Buy
1 Hold
0 Sell
Strong Buy
Apellis Pharmaceuticals
$40.90
$5.25B
130.38%
2 Buy
17 Hold
0 Sell
Hold
Crinetics Pharmaceuticals
$41.00
$3.95B
-7.39
14.62%
8 Buy
0 Hold
0 Sell
Strong Buy
MoonLake Immunotherapeutics
$18.34
$1.24B
-3.40
-57.07%
11 Buy
2 Hold
2 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
KYMR
Kymera Therapeutics
86.08
53.91
167.58%
PTGX
Protagonist Therapeutics
99.36
54.09
119.48%
APLS
Apellis Pharmaceuticals
41.03
23.51
134.19%
CRNX
Crinetics Pharmaceuticals
37.48
4.16
12.48%
AKRO
MLTX
MoonLake Immunotherapeutics
17.06
-23.12
-57.54%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts